CLDN18 and neoplasm: Using a murine model, Wang et al. found that CLDN18-ARHGAP26 could activate the PI3K/AKT-mTOR-FAS pathway and stimu- late fatty acid secretion, thus enhancing metabolism and reproduction in Treg cells and leading to the formation of an immunosuppressive tumor microenvironment [90].